Clinical Trial Update: Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating IKERVIS eye drops administered once daily for quality of vision in dry eye disease patients with severe keratitis has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Keratitis

Drugs mentioned

• Ikervis (ciclosporin ophthalmic emulsion)

Snippet

Sponsor: Santen SAS | Conditions: Keratitis | Phase 4 | Status: COMPLETED | Results posted: 2024-04-18